165 related articles for article (PubMed ID: 33065789)
21. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
22. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction.
ben Anes A; Fetoui H; Bchir S; ben Nasr H; Chahdoura H; Chabchoub E; Yacoub S; Garrouch A; Benzarti M; Tabka Z; Chahed K
Biol Trace Elem Res; 2014 Oct; 161(1):20-31. PubMed ID: 25074430
[TBL] [Abstract][Full Text] [Related]
23. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
24. Effect of terbutaline plus doxofylline on chronic obstructive pulmonary disease.
Luo Q; Peng X; Zhang H
Am J Transl Res; 2021; 13(6):6959-6965. PubMed ID: 34306449
[TBL] [Abstract][Full Text] [Related]
25. Effects of inhaled N-acetylcysteine in combination with terbutaline.
Stiksa G; Nemcek K; Melin S
Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
[TBL] [Abstract][Full Text] [Related]
26. Clinical Effects of Exercise Combined with Respiratory Training in the Rehabilitation Treatment of Patients with Chronic Obstructive Pulmonary Disease.
Wang L; Wu X
Altern Ther Health Med; 2023 Dec; ():. PubMed ID: 38064596
[TBL] [Abstract][Full Text] [Related]
27. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.
Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF
Respir Med; 2005 Dec; 99(12):1511-20. PubMed ID: 16199148
[TBL] [Abstract][Full Text] [Related]
28. Local and systemic oxidative stress status in chronic obstructive pulmonary disease patients.
Zeng M; Li Y; Jiang Y; Lu G; Huang X; Guan K
Can Respir J; 2013; 20(1):35-41. PubMed ID: 23457673
[TBL] [Abstract][Full Text] [Related]
29. Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.
Zhang JQ; Zhang JQ; Liu H; Zhao ZH; Fang LZ; Liu L; Fu WP; Shu JK; Feng JG; Dai LM
Int J Chron Obstruct Pulmon Dis; 2015; 10():917-23. PubMed ID: 25999707
[TBL] [Abstract][Full Text] [Related]
30. Effects of a simple prototype respiratory muscle trainer on respiratory muscle strength, quality of life and dyspnea, and oxidative stress in COPD patients: a preliminary study.
Leelarungrayub J; Pinkaew D; Puntumetakul R; Klaphajone J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1415-1425. PubMed ID: 28553094
[TBL] [Abstract][Full Text] [Related]
31. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.
Decramer M; Rutten-van Mölken M; Dekhuijzen PN; Troosters T; van Herwaarden C; Pellegrino R; van Schayck CP; Olivieri D; Del Donno M; De Backer W; Lankhorst I; Ardia A
Lancet; 2005 Apr 30-May 6; 365(9470):1552-60. PubMed ID: 15866309
[TBL] [Abstract][Full Text] [Related]
32. N-acetylcysteine Attenuates Cigarette Smoke-induced Alveolar Epithelial Cell Apoptosis through Reactive Oxygen Species Depletion and Glutathione Replenish In vivo and In vitro.
Zhao J; Han M; Tian Y; Zhao P; Liu X; Dong H; Feng S; Li J
Curr Pharm Biotechnol; 2023 Oct; ():. PubMed ID: 37921125
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress in patients with COPD and pulmonary hypertension.
Joppa P; Petrásová D; Stancák B; Dorková Z; Tkácová R
Wien Klin Wochenschr; 2007; 119(13-14):428-34. PubMed ID: 17671825
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effects of codonopsis pilosula polysaccharides on the deterioration of impaired phagocytosis of alveolar macrophage induced by fine particulate matter in chronic obstructive pulmonary disease mice].
Chu X; Liu XJ; Qiu JM; Zeng XL; Bao HR
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1134-8. PubMed ID: 27095785
[TBL] [Abstract][Full Text] [Related]
35. [Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].
Xu L; Cai BQ; Zhu YJ; Guo ZJ; Zhang H; Gu L; Xu XX
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):595-9. PubMed ID: 15355665
[TBL] [Abstract][Full Text] [Related]
36. [Effect of lung transplantation on pulmonary function in 5 patients with chronic obstructive pulmonary disease].
Liu JM; Yang WL; Jiang GN; Ding JA; Wang YM; Zheng W; Zhu D; Gao BL; Jiang P; Wu W
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Aug; 28(8):509-12. PubMed ID: 16207394
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the Effect of Mindfulness Behavior Intervention Combined with Progressive Breathing Training on Pulmonary Function Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease.
Yu S; Fan H
Emerg Med Int; 2022; 2022():1698918. PubMed ID: 36065224
[TBL] [Abstract][Full Text] [Related]
38. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Mochizuki H; Nanjo Y; Takahashi H
Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
[TBL] [Abstract][Full Text] [Related]
39. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study.
Stav D; Raz M
Chest; 2009 Aug; 136(2):381-386. PubMed ID: 19447919
[TBL] [Abstract][Full Text] [Related]
40. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
